RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Developing new therapies for patients with glioblastoma (GBM) requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Buxton, Meredith, Alexander, Brian, Berry, Donald, Cavenee, Webster, Colman, Howard, de Groot, John, Ellingson, Benjamin, Gordon, Gary, Khasraw, Mustafa, Lassman, Andrew, Lee, Wenbin, Lim, Michael, Mellinghoff, Ingo, Perry, James, Sulman, Erik, Tanner, Kirk, Weller, Michael, Wen, Patrick, Yung, W K Alfred, Cloughesy, Timothy, Investigators, G B M Agile
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Randomized Trials in Development
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651338/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.816
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados